Chenglai Fu

Chenglai Fu

Auto-generated profile, based on publicly available information

Chenglai Fu

Institute for Developmental and Regenerative Cardiovascular Medicine Xinhua Hospital Shanghai Jiao Tong University School of Medicine 200092 Shanghai China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
WCWeiwei Cheng
Weiwei Cheng
SWShaopeng Wang
Shaopeng Wang
AMAlexander A. Mestre
Alexander A. Mestre
CFChenglai Fu
Chenglai Fu
AMAndres Makarem
Andres Makarem
SSShuying Sun
Shuying Sun
Hexanucleotide repeat expansion inC9ORF72is the most frequent cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we demonstrate that the repeat-associated non-AUG (RAN) translation of (GGGGCC)n-containing RNAs into poly-dipeptides can initiate in vivo without a 5′-cap. The primary RNA substrate for RAN translation of C9ORF72 sense repeats is shown to be the spliced first intron, following its excision from the initial pre-mRNA and transport to the cytoplasm. Cap-independent RAN translation is shown to be upregulated by various stress stimuli through phosphorylation of the α subunit of eukaryotic initiation factor-2 (eIF2α), the core event of an integrated stress response (ISR). Compounds inhibiting phospho-eIF2α-signaling pathways are shown to suppress RAN translation. Since the poly-dipeptides can themselves induce stress, these findings support a feedforward loop with initial repeat-mediated toxicity enhancing RAN translation and subsequent production of additional poly-dipeptides through ISR, thereby promoting progressive disease.

27 October 2016 in eLife
Verified
Journal Article
Open access
RLRuo-Jing Li
Ruo-Jing Li
JXJing Xu
Jing Xu
CFChenglai Fu
Chenglai Fu
JZJing Zhang
Jing Zhang
YZYujun George Zheng
Yujun George Zheng
JLJun O Liu
Jun O Liu
Blockade of lysosomal calcium release due to lysosomal lipid accumulation has been shown to inhibit mTORC1 signaling. However, the mechanism by which lysosomal calcium regulates mTORC1 has remained undefined. Herein we report that proper lysosomal calcium release through the calcium channel TRPML1 is required for mTORC1 activation. TRPML1 depletion inhibits mTORC1 activity, while overexpression or pharmacologic activation of TRPML1 has the opposite effect. Lysosomal calcium activates mTORC1 by inducing association of calmodulin (CaM) with mTOR. Blocking the interaction between mTOR and CaM by antagonists of CaM significantly inhibits mTORC1 activity. Moreover, CaM is capable of stimulating the kinase activity of mTORC1 in a calcium-dependent manner in vitro. These results reveal that mTOR is a new type of CaM-dependent kinase, and TRPML1, lysosomal calcium and CaM play essential regulatory roles in the mTORC1 signaling pathway.

1 April 2014 in Molecular Cell
Verified
Journal Article
Closed access
FRFeng Rao
Feng Rao
JCJiyoung Cha
Jiyoung Cha
JXJing Xu
Jing Xu
RXRisheng Xu
Risheng Xu
MVM. Scott Vandiver
M. Scott Vandiver
SSSolomon H. Snyder
Solomon H. Snyder

23 January 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
FRFeng Rao
Feng Rao
JXJing Xu
Jing Xu
CFChenglai Fu
Chenglai Fu
JCJiyoung Y. Cha
Jiyoung Y. Cha
MGMoataz M. Gadalla
Moataz M. Gadalla
SSSolomon H. Snyder
Solomon H. Snyder
Significance: Inositol pyrophosphates are messenger molecules incorporating the energetic pyrophosphate bond. Although they have been implicated in diverse biologic processes, their physiologic functions remain enigmatic. We show that the catalytic activity of inositol hexakisphosphate kinase 2 (IP6K2), one of the principal enzymes generating the inositol pyrophosphate IP7 (5-diphosphoinositolpentakisphosphate), mediates cancer cell migration and tumor metastasis both in cell culture and intact mice. In this process, IP6K2 diminishes cell–cell adhesion, enabling cells to invade the intercellular matrix. Drugs that inhibit IP6K2 may be beneficial in cancer therapy.

2 February 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CFChenglai Fu
Chenglai Fu
JXJing Xu
Jing Xu
WCWeiwei Cheng
Weiwei Cheng
TRTomas Rojas
Tomas Rojas
ACAlfred C. Chin
Alfred C. Chin
SSSolomon H. Snyder
Solomon H. Snyder
Inositol hexakisphosphate kinase 1 (IP6K1), which generates 5-diphosphoinositol pentakisphosphate (5-IP7), physiologically mediates numerous functions. We report that IP6K1 deletion leads to brain malformation and abnormalities of neuronal migration. IP6K1 physiologically associates with α-actinin and localizes to focal adhesions. IP6K1 deletion disrupts α-actinin’s intracellular localization and function. The IP6K1 deleted cells display substantial decreases of stress fiber formation and impaired cell migration and spreading. Regulation of α-actinin by IP6K1 requires its kinase activity. Deletion of IP6K1 abolishes α-actinin tyrosine phosphorylation, which is known to be regulated by focal adhesion kinase (FAK). FAK phosphorylation is substantially decreased in IP6K1 deleted cells. 5-IP7, a product of IP6K1, promotes FAK autophosphorylation. Pharmacologic inhibition of IP6K by TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] recapitulates the phenotype of IP6K1 deletion. These findings establish that IP6K1 physiologically regulates neuronal migration by binding to α-actinin and influencing phosphorylation of both FAK and α-actinin through its product 5-IP7.

5 August 2015 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
CFChenglai Fu
Chenglai Fu
JXJing Xu
Jing Xu
RLRuo-Jing Li
Ruo-Jing Li
JCJoshua A. Crawford
Joshua A. Crawford
AKA. Basit Khan
A. Basit Khan
SSSolomon H. Snyder
Solomon H. Snyder
The inositol hexakisphosphate kinases (IP6Ks) are the principal enzymes that generate inositol pyrophosphates. There are three IP6Ks (IP6K1, 2, and 3). Functions of IP6K1 and IP6K2 have been substantially delineated, but little is known of IP6K39s role in normal physiology, especially in the brain. To elucidate functions of IP6K3, we generated mice with targeted deletion of IP6K3. We demonstrate that IP6K3 is highly concentrated in the brain in cerebellar Purkinje cells. IP6K3 physiologically binds to the cytoskeletal proteins adducin and spectrin, whose mutual interactions are perturbed in IP6K3-null mutants. Consequently, IP6K3 knock-out cerebella manifest abnormalities in Purkinje cell structure and synapse number, and the mutant mice display deficits in motor learning and coordination. Thus, IP6K3 is a major determinant of cytoskeletal disposition and function of cerebellar Purkinje cells. SIGNIFICANCE STATEMENT We identified and cloned a family of three inositol hexakisphosphate kinases (IP6Ks) that generate the inositol pyrophosphates, most notably 5-diphosphoinositol pentakisphosphate (IP7). Of these, IP6K3 has been least characterized. In the present study we generated IP6K3 knock-out mice and show that IP6K3 is highly expressed in cerebellar Purkinje cells. IP6K3-deleted mice display defects of motor learning and coordination. IP6K3-null mice manifest aberrations of Purkinje cells with a diminished number of synapses. IP6K3 interacts with the cytoskeletal proteins spectrin and adducin whose altered disposition in IP6K3 knock-out mice may mediate phenotypic features of the mutant mice. These findings afford molecular/cytoskeletal mechanisms by which the inositol polyphosphate system impacts brain function.